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Objectives: In this study, 210 women with vaginal discharge and other symptoms/signs of genital pathology
suggestive of vulvovaginal candidiasis (VVC) were involved in order to distinguish true VVC and cytolytic
vaginosis (CV) cases.
Methods: Fungal cultures, 10% potassium hydroxide (KOH) and Gram stained preparations and pH
measurements were performed on the vaginal discharge material of each patient.
Results: Fifteen patients (7.1%) were diagnosed with cytolytic vaginosis according to their clinical and
microbiological ﬁndings, including abundant lactobacilli, fragmented epithelial cells and/or free nuclei due to
cytolysis, seen in their discharge materials on microscopic examination, but no fungal growth.
Conclusions: The results of this study may contribute to the reports in the literature indicating the importance
of such disorders, which are generally misdiagnosed as candidiasis.
Key words: VAGINAL DISCHARGE;D YSPAREUNIA;D YSURIA;I TCHING
INTRODUCTION
In healthy women Lactobacilli are predominant
organisms in the cervix and vagina. They
maintain the acidic pH (4.0–4.5%) of the vagina
by producing lactic acid, thereby protecting the
vagina against infections
1.
Lactobacilli may control the overgrowth of
E.coli, Candida spp., Gardnerella vaginalis and
Mobilincus spp. by producing H2O2 and other
inhibitory substances such as acidolin, and by
competing for nutrients
2–4.
In some women, who are still in the
reproductive stage of life, an abundant growth
of lactobacilli may result in lysis of vaginal
epithelial cells
5,6. This change in the vaginal
microenvironment may lead to symptoms such
as pruritus, burning and abundant severe whitish
discharge, similar to symptoms of candidal
vaginitis
5. On microscopic examination, large
amounts of lactobacilli and fragmented or lysed
epithelial cells are observed; thus the disorder is
called ‘cytolytic vaginosis’ (CV) in the litera-
ture
7.
This study was carried out to assess CV cases in
a group of patients with symptoms and signs
suggestive of vulvovaginal candidiasis (VVC).
MATERIALS AND METHODS
Patients
In this study, 210 women that were all within the
reproductive age group, exhibiting symptoms of
abnormal vaginal discharge, pruritus, burning and
dyspareunia or signs of inﬂammation of the
genital tract suggestive of VVC, were clinically
and microbiologically evaluated. Vaginal dis-
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the pool were obtained by using cotton swabs
after the insertion of a speculum.
Microbiological studies
Three samples were obtained from each patient’s
discharge material by using sterile swabs. The
three swabs were placed in Stuart’s transport
medium.
One swab was used to assess pH of the
discharge by means of pH indicator paper
(Merck, Germany), immediately after collecting
the sample. The second swab was used for
inoculation on Sabouraud dextrose agar (SDA)
plates, which were incubated at 358C for 3 days.
The third swab was mixed with 10% KOH as a
wet mount and Gram stained preparation, in
order to look for the presence of yeast cells and/
or pseudohyphae or disrupted epithelia and
abundant lactobacilli as indicators of VVC and
CV, respectively
7,8.
RESULTS
During the study period 210 women suggestive of
VVC were evaluated. None of these women
were pregnant, and only one had diabetes mellitus
which was under control. All of these patients
were suffering from a whitish vaginal discharge.
The other complaints and signs included malodor
in 33 patients (15.7%), pruritus in 32 patients
(15.2%), erythema and edema of vulva or vagina
in 21 patients (10%), burning in 15 patients (7.1%)
and dyspareunia in nine patients (4.3%).
Twenty-seven (12.8%) individuals were diag-
nosed as having active VVC conﬁrmed by
cultures on SDA, and/or microscopy, while 15
patients (7.1%) did not have any positive culture
results for yeasts on SDA, but on Gram stained
preparations of their vaginal discharges, abundant
lactobacilli and many fragmented epithelial cells
and/or free nuclei were observed (Figures 1 and
2). Depending on the clinical and microbiological
ﬁndings stated in the literature, all were diagnosed
Figure 1 Lactobacilli and disrupted epithelial cells
Figure 2 Lactobacilli and free nucleus of a lysed
epithelium
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5. Leucocytes were not observed in
samples belonging to the patients diagnosed as
having CV; except for two samples which
revealed a few leucocytes in the microscopic
ﬁeld. A pH of 4.0–4.5 was detected in all
discharge samples.
All of these 15 cases were in the reproductive
age group of 25–40 years. Five (33.3%) were in
the luteal phase, with enhanced complaints of
discharge and pruritus.
DISCUSSION
Normal vaginal ﬂora in adult women within the
reproductive age group is usually dominated with
lactobacilli. Lactobacilli in low numbers (ﬁve
bacilli per 10 squamous cells) in vaginal discharges
have been deﬁned as protective factors against
vaginal candidiasis
9.
According to several studies lactobacilli build
up a barrier against candidal overgrowth by
blocking the adhesion of yeasts to epithelial cells
through competition for nutrients
10–13. How-
ever, among individuals within the reproductive
age group some may develop CV due to an excess
amount of lactobacilli. In such cases, lactobacilli
alone or with other bacteria may cause dissolution
of the vaginal intermediate epithelium that may
result in the presence of free nuclei. This
dissolution may be responsible for complaints of
dysuria
5.
Fifteen patients had severe vaginal discharge
and/or additional manifestations suggestive of
VVC. Most of them had a history of failure of
repeated antifungal therapy regimens for sus-
pected recurrent VVC (RVVC), indicating that
the clinical picture was non-candidal vaginitis
and was misdiagnosed. Indeed, microscopy
revealed disrupted squamous epithelial cells
and/or free nuclei due to cytolysis and an
abundant number of lactobacilli, instead of any
fungal structures. Another remarkable point was
the absence of leucocytes on Gram preparations
in all but two of the samples.
One of our patients had diabetes mellitus.
Some authors claim that the lactobacilli are more
abundant in women with high serum glucose
levels
10. We also detected that ﬁve (33.3%) of our
patients who had complaints of increased dis-
charge and itching were in their luteal phase. It
has been suggested that in the luteal phase there is
a remarkable rise in the number of colonizing
lactobacilli
4. After a correct diagnosis, the treat-
ment may be directed toward reducing the
number of lactobacilli by elevating the pH with
alkaline douches such as Na-bicarbonate solu-
tion
5,7. The two patients who received the
treatment beneﬁted from it.
The clinical condition called CV was pre-
viously known as ‘lactobacillus overgrowth
syndrome’ or ‘Doderlein’s cytolysis’, because the
typical disruption of epithelial cells is associated
with the digestive activity of lactobacilli
4,14.
Although an old phenomenon, the exact me-
chanisms leading to fragmentation or cytolysis of
vaginal epithelia in those women are not known.
Abundant lactobacilli covering the fragmented
epithelial cells may be confused with the ‘clue
cells’ of bacterial vaginosis (BV), these are there-
fore called ‘false clue cells’
7. In the literature, we
found no studies that mentioned a confusion
between BV and CV according to the micro-
scopic appearance. BV may be diagnosed by pH
measurements and ‘whiff’ tests. All of our cases
yielded acidic pH (4.0–4.5) with negative whiff
tests, which were sufﬁcient for ruling out BV. In
one study, the number of patients diagnosed with
CV was deﬁned as only ﬁve in 101 women with
abundant vaginal discharge
15. In our study there
were 210 patients with remarkable vaginal
discharge and the detected CV cases were 15
(7.1%), which is in agreement with the previous
ﬁnding.
The diagnosis of CV seems to bother
clinicians and patients because it also mimics
VVC and most of the cases that are accepted as
‘chronic VVC’ which is unresponsive to anti-
fungal drugs, are waiting for the correct medical
approach
16. However in one study, of 271
patients with vulvovaginal complaints, 29
(10.7%) were diagnosed as having suggestive
VVC, but only 16 (5.9%) had a conﬁrmed
diagnosis of candidiasis
14. Although not reported
in the article, the remaining 13 cases could have
been diagnosed as CV, if the authors had
searched for that condition.
While VVC is accepted as an important genital
disorder comprising 10–30% of all vulvovaginal
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tion of 5–7% in the same patient population,
must not be disregarded, but is to be taken as a
signiﬁcant clinical condition.
According to data given in the literature, most
patients have been treated with antifungal med-
ications, although Candida spp. has not been
identiﬁed
7,17.
In conclusion, the differentiation of CV from
VVC and other similar disorders would prevent
the clinician from giving inappropriate and useless
treatment to the patient.
CONCLUSIONS
1. In this study the rate of CV cases among
women with suggestive VVC was found to
be 7.1%.
2. The results of this study, much like the
previous studies in the literature, illustrate the
importance of being careful when evaluating
women with presumed vaginal candidiasis. A
misdiagnosis can lead to the patient pestering
their gynecologist again and again in order to
resolve their complaint, and means that they
are originally treated with drugs that are
useless for CV.
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